GO:0180035 lncRNA processing: Biogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0180035 lncRNA processing is defined as any process involved in the conversion of one or more primary lncRNA transcripts into one or more mature lncRNA molecules.
• Maturation of lncRNAs includes 5-prime capping, splicing, 3-prime end formation, and chemical modification, and these steps influence lncRNA stability, localization, and function.
• lncRNAs act through diverse mechanisms including miRNA sponging, chromatin regulation, and post-translational modification of proteins.
• Dysregulated lncRNA processing and function are implicated in cancers such as colorectal cancer and in kidney diseases.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of lncRNA processing factors and lncRNA loci.
• Combining RNA-seq, Ribo-seq, proteomics, and imaging provides a multi-layered view of lncRNA maturation and function.
Description
Long noncoding RNAs (lncRNAs) are transcripts that are not translated into proteins and that participate in numerous regulatory processes in cells. The Gene Ontology term GO:0180035 lncRNA processing describes the set of molecular events that convert primary lncRNA transcripts into mature lncRNA molecules, including steps such as capping, splicing, 3-prime end formation, and chemical modification. Understanding this process is essential because the mature form, stability, and localization of a lncRNA determine its ability to function in gene regulation and cellular physiology. lncRNA processing is not merely a housekeeping step; it directly shapes the functional repertoire of lncRNAs. For example, processed lncRNAs can act as competing endogenous RNAs that sponge microRNAs and modulate gene expression networks. They can also guide chromatin-modifying complexes or influence post-translational modifications of proteins, thereby affecting energy metabolism and immune responses. Consequently, defects in lncRNA processing or in the processing machinery can contribute to disease, including colorectal cancer and kidney disorders. For researchers, GO:0180035 provides a structured framework to annotate and investigate lncRNA maturation. By combining CRISPR-based genetic models with transcriptomic and proteomic readouts, it is now possible to dissect which processing steps are required for specific lncRNA functions and how their disruption contributes to human disease. This article summarizes the definition, mechanism, key genes, disease links, and experimental methods relevant to lncRNA processing.
lncRNA processing At A Glance
| GO ID | GO:0180035 |
|---|---|
| GO term | lncRNA processing |
| Ontology | biological_process |
| Synonym | None |
| Definition | Any process involved in the conversion of one or more primary lncRNA transcripts into one or more mature lncRNA molecules. |
| Major function | Maturation of primary lncRNA transcripts into stable, functional lncRNA molecules through capping, splicing, 3-prime end formation, and modification. |
| Related processes | RNA splicing, RNA 3-prime end processing, RNA modification, and lncRNA-mediated gene regulation. |
| Disease relevance | Dysregulation of lncRNA processing and function is associated with cancers such as colorectal cancer and with kidney diseases. |
What Is GO:0180035?
GO:0180035 lncRNA processing is a biological process defined as any process involved in the conversion of one or more primary lncRNA transcripts into one or more mature lncRNA molecules. In practice, this includes co-transcriptional and post-transcriptional events such as 5-prime capping, splicing, 3-prime end cleavage and polyadenylation, and chemical modifications that together produce a stable, functional lncRNA.
Why Is lncRNA processing Important in Cell Biology?
lncRNA processing is important because it determines whether a primary lncRNA transcript becomes a stable, correctly localized, and functional RNA molecule. Mature lncRNAs participate in diverse regulatory roles, including miRNA sponging, chromatin modulation, and post-translational regulation of proteins, and these functions influence cancer biology, immune escape, and kidney disease. Studying GO:0180035 therefore helps researchers connect RNA maturation steps to physiological and pathological outcomes.
• Maturation steps such as capping, splicing, and 3-prime end formation determine lncRNA stability and function.
• Processed lncRNAs can act as competing endogenous RNAs that sponge microRNAs and modulate gene expression.
• lncRNAs influence post-translational modifications and energy metabolism in cancer cells.
• lncRNA processing and function are linked to colorectal cancer biology and clinical settings.
• The lncRNA TUG1 is implicated in kidney diseases, highlighting the disease relevance of lncRNA processing.
• CRISPR-based models allow causal testing of lncRNA processing factors and lncRNA loci.
• Multi-omics methods such as RNA-seq and proteomics can resolve processing intermediates and mature lncRNAs.
• Understanding lncRNA processing may reveal biomarkers and therapeutic targets for cancer and other diseases.
What Happens During lncRNA processing?
Transcription and 5-prime capping
In simple terms: The lncRNA gene is copied into an RNA strand, and a protective cap is added to its front end.
lncRNA processing begins with transcription of a primary lncRNA transcript by RNA polymerase II, followed by addition of a 5-prime cap. This cap protects the RNA and helps recruit factors needed for subsequent maturation steps. The resulting primary transcript is the substrate for further processing events that convert it into a mature lncRNA.
Splicing and exon definition
In simple terms: Unwanted middle pieces are cut out and the remaining pieces are joined together.
Many lncRNAs undergo splicing, in which introns are removed and exons are ligated. Splicing can generate different lncRNA isoforms and influences which sequences are retained in the mature molecule. The splicing machinery therefore contributes directly to the conversion of primary lncRNA transcripts into mature lncRNAs.
3-prime end formation and polyadenylation
In simple terms: The back end of the RNA is trimmed and a tail is added to make it stable.
3-prime end cleavage and polyadenylation generate a defined end for many lncRNAs and enhance their stability. This step is part of the maturation process that yields a functional lncRNA capable of interacting with proteins, DNA, or other RNAs.
Chemical modification and quality control
In simple terms: Small chemical tags are added to the RNA, and quality checks decide whether it is kept or degraded.
Chemical modifications such as methylation can alter lncRNA structure, interactions, and half-life. Quality-control pathways monitor correctly processed lncRNAs and target improperly processed transcripts for degradation. Together, these events ensure that only appropriately matured lncRNAs accumulate in the cell.
Nuclear export and localization
In simple terms: The finished RNA is sent to the right part of the cell where it will work.
After maturation, lncRNAs are localized to specific cellular compartments, including the nucleus and cytoplasm. Correct localization is essential for their regulatory functions, such as chromatin modulation in the nucleus or miRNA sponging in the cytoplasm.
Key Genes Involved in GO:0180035 lncRNA processing
The following genes and proteins are involved in lncRNA processing and in the functional roles of mature lncRNAs, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNA polymerase II | Transcribes primary lncRNA transcripts | Core enzyme for lncRNA biogenesis |
| Capping enzymes | Add 5-prime cap to lncRNAs | Required for lncRNA stability and processing |
| Splicing factors | Catalyze intron removal and exon ligation | Determine lncRNA isoform composition |
| Cleavage and polyadenylation factors | Generate 3-prime ends of lncRNAs | Essential for lncRNA maturation and stability |
| RNA methyltransferases | Add chemical modifications to lncRNAs | Modulate lncRNA structure and function |
| TUG1 | lncRNA involved in kidney diseases | Model for lncRNA processing and disease |
| H19 | lncRNA with roles in cancer biology | Studied in colorectal cancer and other cancers |
| MALAT1 | lncRNA involved in gene regulation | Frequently studied in cancer and RNA processing |
| NEAT1 | lncRNA component of nuclear bodies | Linked to RNA processing and cellular stress |
| XIST | lncRNA involved in X-chromosome inactivation | Classic example of functional lncRNA processing |
| HOTAIR | lncRNA that modulates chromatin | Studied in cancer and gene regulation |
| PVT1 | lncRNA implicated in cancer | Investigated in colorectal cancer and other malignancies |
| CCAT1 | lncRNA associated with colorectal cancer | Potential biomarker and therapeutic target |
| GAS5 | lncRNA with growth-suppressive roles | Studied in cancer and miRNA sponging |
| MEG3 | lncRNA with tumor-suppressive functions | Investigated in cancer biology |
| SNHG family | lncRNAs involved in ribosome-related processes | Studied in cancer and RNA processing |
| NORAD | lncRNA that sequesters RNA-binding proteins | Model for lncRNA function and processing |
How Is lncRNA processing Regulated?
lncRNA processing is regulated at multiple levels. Transcription by RNA polymerase II determines the amount of primary transcript available for maturation, while splicing and 3-prime end formation are controlled by the availability and activity of the corresponding processing factors. Chemical modifications can alter lncRNA stability and interactions, and quality-control pathways can degrade improperly processed transcripts. In addition, lncRNAs themselves can regulate gene expression through miRNA sponging and chromatin modulation, creating feedback loops that influence cellular states such as cancer and immune escape.
lncRNA processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TUG1 | Kidney diseases | Knockout and overexpression models in kidney cell lines |
| H19 | Colorectal cancer | Knockout and overexpression in colorectal cancer cell lines |
| PVT1 | Colorectal cancer | Knockout and point mutation models |
| CCAT1 | Colorectal cancer | Knock-in reporter and overexpression models |
| MALAT1 | Cancer and RNA processing | Knockout and tagged knock-in models |
lncRNA processing in colorectal cancer
Colorectal cancer is a major disease context in which lncRNA processing and function have been studied. Dysregulated lncRNAs can act as competing endogenous RNAs that sponge microRNAs and modulate gene expression networks, contributing to tumor biology and clinical outcomes. Specific lncRNAs such as H19, PVT1, and CCAT1 have been investigated as potential biomarkers and therapeutic targets in colorectal cancer. In addition, lncRNAs influence immune escape and immunotherapy responses in colorectal cancer, highlighting the clinical importance of understanding their processing and function.
lncRNA processing in kidney diseases
The lncRNA TUG1 has been implicated in kidney diseases, where its processing and functional interactions influence cellular stress responses and disease progression. Studies of TUG1 provide a model for how lncRNA maturation and function can be linked to organ-specific pathology, and they support the broader relevance of GO:0180035 to human disease.
lncRNA processing in cancer metabolism and post-translational regulation
lncRNAs can mediate post-translational modifications and reprogram energy metabolism in cancer cells, linking RNA processing to metabolic adaptation. These functions depend on the mature lncRNA being correctly processed and localized, underscoring the importance of GO:0180035 in cancer biology.
From lncRNA processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate lncRNA required for a specific phenotype? | CRISPR knockout cell model |
| Does a specific processing site or modification matter? | Point mutation model |
| How does a disease-associated variant affect lncRNA processing? | Knock-in model |
| Where and when is a lncRNA expressed? | Tagged knock-in reporter model |
| Does increased lncRNA dosage alter cellular behavior? | Overexpression model |
| Which processing factors interact with a lncRNA? | Affinity purification with tagged knock-in |
How to Study the lncRNA processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | lncRNA expression and splicing | Identify processed lncRNA isoforms |
| Ribo-seq | Ribosome occupancy | Confirm noncoding status of lncRNAs |
| Mass spectrometry | Protein interactions | Identify lncRNA processing factors |
| Fluorescence in situ hybridization | lncRNA localization | Determine nuclear vs cytoplasmic distribution |
| CRISPR knockout | Gene requirement | Test causal role of processing factors |
| CRISPR point mutation | Specific site function | Test processing signals and modifications |
| CRISPR knock-in | Tagged or variant lncRNA | Track expression and interactions |
| Overexpression | Dosage effects | Model lncRNA gain-of-function |
RNA sequencing and transcriptome analysis
RNA-seq can identify lncRNA transcripts, quantify their expression, and reveal splicing patterns and 3-prime end usage. These data help define which primary transcripts are processed into mature lncRNAs and how processing changes across conditions.
Ribo-seq and translation profiling
Ribo-seq measures ribosome occupancy and can be used to confirm that a lncRNA is noncoding or to detect small open reading frames. This is important for distinguishing lncRNA processing from coding RNA maturation.
Proteomics and interaction studies
Proteomic methods such as mass spectrometry can identify proteins that bind lncRNAs and participate in their processing or function. These approaches help map the protein machinery involved in lncRNA maturation.
Imaging and localization assays
Fluorescence in situ hybridization and live-cell imaging can determine where a lncRNA localizes after processing. Localization is a key indicator of lncRNA function and can be linked to disease phenotypes.
How CRISPR Can Be Used to Study GO:0180035 lncRNA processing
Knockout
CRISPR knockout can delete a lncRNA gene or a processing factor to test whether it is required for a phenotype. This approach is widely used to study lncRNA function and processing in cancer and other diseases.
Point Mutation
Point mutations can be introduced at specific processing sites, such as splice sites or modification sites, to determine their contribution to lncRNA maturation and function.
Knock-in
Knock-in strategies can add tags or disease-associated variants to a lncRNA locus, enabling tracking of processed transcripts and testing of variant effects on processing.
Overexpression
Overexpression models increase lncRNA dosage to study gain-of-function effects and to determine whether excess mature lncRNA alters cellular behavior.
How EDITGENE Supports lncRNA processing Research
Researchers studying lncRNA processing-related genes often need to determine whether a candidate gene is causally involved in lncRNA maturation and function. EDITGENE provides CRISPR-based cell models and screening services that enable such causal tests in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for lncRNA processing research.
Frequently Asked Questions About lncRNA processing
What is lncRNA processing?
lncRNA processing (GO:0180035) is any process involved in the conversion of one or more primary lncRNA transcripts into one or more mature lncRNA molecules, including capping, splicing, 3-prime end formation, and modification.
What genes are involved in lncRNA processing?
Genes involved include RNA polymerase II, capping enzymes, splicing factors, cleavage and polyadenylation factors, and RNA methyltransferases, as well as specific lncRNAs such as TUG1, H19, and MALAT1.
Why is lncRNA processing important?
It determines the stability, localization, and function of lncRNAs, which participate in gene regulation, cancer biology, immune escape, and kidney disease.
How is lncRNA processing studied?
It is studied using RNA-seq, Ribo-seq, proteomics, imaging, and CRISPR-based knockout, point mutation, knock-in, and overexpression models.
What diseases are linked to lncRNA processing?
Colorectal cancer and kidney diseases are among the diseases linked to lncRNA processing and function.
What is the GO ID for lncRNA processing?
The GO ID is GO:0180035, and the ontology aspect is biological_process.
Can CRISPR be used to study lncRNA processing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to test the role of lncRNA genes and processing factors.
What is the role of TUG1 in disease?
TUG1 is an lncRNA implicated in kidney diseases, and its processing and function are studied as a model for lncRNA-related pathology.
How do lncRNAs regulate gene expression?
Mature lncRNAs can sponge microRNAs, modulate chromatin, and influence post-translational modifications, thereby regulating gene expression.
What services does EDITGENE provide for lncRNA research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for lncRNA processing research.
Conclusion
GO:0180035 lncRNA processing defines the maturation of primary lncRNA transcripts into functional mature lncRNAs through capping, splicing, 3-prime end formation, and modification. These steps are critical because mature lncRNAs regulate gene expression, cellular metabolism, and immune responses, and their dysregulation is linked to colorectal cancer and kidney diseases. By combining CRISPR-based genetic models with transcriptomic, proteomic, and imaging methods, researchers can dissect the mechanisms and disease relevance of lncRNA processing. EDITGENE supports these efforts with customizable cell models and screening services tailored to lncRNA biology.
References
- 1. Tan YT et al.. 2021. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer.. Cancer Commun (Lond) 41(2):109-120 PMID: 33119215
- 2. Talebi A et al.. 2020. The relevance of long noncoding RNAs in colorectal cancer biology and clinical settings.. J Cancer Res Ther 16(Supplement):S22-S33 PMID: 33380647
- 3. Alkan AH et al.. 2022. Endogenous miRNA Sponges.. Methods Mol Biol 2257:91-104 PMID: 34432275
- 4. Charles Richard JL et al.. 2018. Platforms for Investigating LncRNA Functions.. SLAS Technol 23(6):493-506 PMID: 29945466
- 5. Zhang D et al.. 2025. Functions and mechanisms of lncRNAs in immune escape and their application in immunotherapy for colorectal cancer.. J Transl Med 23(1):689 PMID: 40537762
- 6. Chen T et al.. 2025. lncRNA TUG1 and kidney diseases.. BMC Nephrol 26(1):139 PMID: 40108517
- 7. Wang L et al.. 2019. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.. Int J Mol Sci 20(22) PMID: 31744051
- 8. Guo C et al.. 2020. Pathophysiological Functions of the lncRNA TUG1.. Curr Pharm Des 26(6):688-700 PMID: 31880241
